Antibacterial therapy in cystic fibrosis.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 2186247.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Bacterial lung infections determine the prognosis for most cystic fibrosis patients. The antibacterial therapy is difficult because of the host-bacterium interaction and altered pharmacokinetics. The new insights in the working mechanisms of antibiotics that may lead to better treatment results have been discussed, and guidelines for treatment of lung infections in cystic fibrosis patients were given.
Medical subject headings
- Anti-Bacterial Agents
- Cystic Fibrosis
- Respiratory Tract Infections